Immunotherapy for Triple-Negative Breast Cancer

Immunotherapy for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is characterized by extensive tumor heterogeneity at both the pathologic and molecular levels, particularly accelerated aggressiveness, and terrible metastasis. It is responsible for the increased mortality of breast cancer patients. Due to the negative expressio...

Full description

Bibliographic Details
Main Authors: Yifeng Cao, Chuyang Chen, Yi Tao, Weifeng Lin, Ping Wang
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceutics
Subjects:
TNBC
immunotherapy
immune checkpoint
nanocarrier
drug delivery
combinational immunotherapy
Online Access:https://www.mdpi.com/1999-4923/13/12/2003

Internet

https://www.mdpi.com/1999-4923/13/12/2003

Similar Items